Physician profile
John M Pap
NPI 1093750085
$321.72
in general payments reported to CMS, 2019-2025
9 companies · $6.27 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2020: $56.21 · 2021: $50.33 · 2023: $50.80 · 2025: $6.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $57.07.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $57.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $106.44 | 2019-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $46.75 | 2020-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $42.70 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $34.75 | 2019 | |
| Astellas Pharma US INC | $34.38 | 2019 | |
| Amgen INC. | $19.74 | 2023 | Repatha |
| Pfizer INC. | $12.94 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.61 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Pap listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.